High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma is a research paper published in Blood (2023). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
BLRD VA
Grant: I01 BX001584
NCI NIH HHS
Grant: P50 CA100707
NCI NIH HHS
Grant: K08 CA252174
NCI NIH HHS
Grant: R01 CA262710
NCI NIH HHS
Grant: P01 CA155258
MeSH Terms